Circulating Tumor Cells Market Size, Share, Analysis, Research, Key Players, Diagnostics and Forecast (2023)

Global Circulating Tumor Cell (CTC) Market by Technology (CTC Detection and Enrichment Methods, CTC Direct Detection Methods, CTC Analysis), Product (Kits and Reagents, Blood Collection Tubes, Devices or Systems), Sample (Blood, Bone Marrow, Other Body Fluids) Application (Liquid Biopsy/Clinical, Research), End User (Hospitals, Clinics, Research & Academic Institutes, Diagnostic Centers, Other), Country (US, Canada, Mexico, Germany, Italy, UK, France, Spain, Netherlands). , Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia Pacific, Brazil, Argentina, Rest of South America, South Africa , Saudi Arabia , United Arab Emirates, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecasts to 2028

(Video) Circulating Tumor Cell Test (Biocept)

Market Analysis and Market Insights Circulating Tumor Cells (CTC)

Circulating Tumor Cells (CTC) Market is anticipated to gain market growth during the forecast period 2021 to 2028. Data Bridge Market Research forecasts that the market will be worth US$26.12 billion by 2028 and will grow at a CAGR of 12.71% over the above forecast period.

Circulating tumor cells (CTC) are the type of cells normally found in the vasculature, or lymphatics, carried by a tumor and through the bloodstream and transported throughout the body. The CTC test is designed to help the oncologist determine whether the patient has metastatic breast, prostate, or colon cancer.

Raising awareness of the use of CTC inKrebsManagement is among the important factors which are expected to increase the growth and demand in the Circulating Tumor Cells (CTC) market. in the global market during the forecast period of 2021 to 2028. In addition, the increase in the prevalence of multiple chromosomal abnormality syndrome and the presence of sophisticated healthcare infrastructure are also expected to increase the growth of the market. Furthermore, the high prevalence of preventive medicine and the rapid development of cluster chip technology is one of the significant factors expected to drive the growth of circulating tumor cell (CTC) market.

(Video) Global Circulating Tumor Cell Market Size, Trends & Analysis - Forecasts To 2026

The rapid technological advancement, development in biomedical imaging and biotechnological procedures, as well as the high demand for efficient diagnostic and screening tests are expected to provide significant growth opportunities for the market during the forecast period 2021 to 2028.

However, the lack of awareness of advanced CTC technologies and high CTC costs are expected to restrain the growth of the circulating tumor cell (CTC) market, while the increasing prevalence of point-of-care testing will restrain the growth of the circulating tumor cell (CTC) market circulating tumor cells (CTC).

This Circulating Tumor Cells (CTC) Market report provides details on recent new developments, trade regulations, import-export analysis, production analysis, value chain optimization, market shares, impact of domestic and local market players, analyzing opportunities in terms of emerging revenue streams, changes in market regulation, strategic Analysis of market growth, market size, category market growth, application and domain niches, product approvals, product launches, geographic expansions, technological innovations in the market. For more information on Circulating Tumor Cells (CTC) Market, please contact Data Bridge Market Research aanalyst summary,Our team will help you make an informed market decision to achieve market growth.

(Video) Global 2025 Circulating Tumor Cells (CTC) Market Insights, Trends and Major Key Players Analysis

GlobalCirculating Tumor Cells (CTC) MarketScope and size of the market

The circulating tumor cells (CTC) market is segmented by technology, product, sample, application and end-user. The growth in these segments will help you analyze the tight growth segments in industries and provide users with valuable market overview and market insights to help them make strategic decisions to identify key market applications.

  • On the basis of technology, the circulating tumor cells (CTC) market is segmented into CTC enrichment and detection methods, direct CTC detection methods and CTC analysis. CTC enrichment and detection methods have been further subdivided into immunocapture methods (label-based), size-based sorting (unlabeled), density-based sorting (unlabeled), and combination methods (unlabeled). Immunocapture (label-based) is further divided into positive selection and negative selection. Size-based separation (no label) is further divided into membrane-based and microfluidics. Direct CTC detection methods have been further subdivided into SERS,Microscopyand other.
  • On the basis of product, Circulating Tumor Cells (CTC) market is segmented into Kits & Reagents, Blood Collection Tubes, and Devices or Systems.
  • Based on Sample Circulating Tumor Cells (CTC) Market is segmented into:blood,bone marrowand other body fluids.
  • Circulating Tumor Cells (CTC) market application segment is segmented into Research and Clinical/Liquid Biopsy. Clinical/liquid biopsy has been further subdivided into risk assessment, screening, and surveillance. Research was further divided into cancer stem cell and tumorigenesis research and drug/therapeutic development
  • Based on end-user, the circulating tumor cells (CTC) market is segmented into hospitals, clinics, academic and research institutes, diagnostic centers, and others.

Circulating Tumor Cells (CTC) MarketCountry level analysis

The Circulating Tumor Cells (CTC) market is analyzed and as mentioned above, insights are provided on the market size and trends by country, technology, product, sample, application and end-user.

Countries covered in Circulating Tumor Cells (CTC) Market report are USA, Canada & Mexico in North America, Germany, France, UK, Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China and Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia Pacific (APAC), Saudi Arabia, United Arab Emirates, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

(Video) Siegfried Hauch-The molecular analysis on circulating tumor cells to determine prognostic and predic

The North America region is a leader in the circulating tumor cell (CTC) market due to its well-established healthcare infrastructure and high uptake of advanced diagnostic technologies. Asia-Pacific is expected to expand at a significant growth rate during the forecast period 2021 to 2028 due to high unmet diagnostic needs and rapidly increasing patient awareness of cancer screening and risk assessment.

The country section of the Circulating Tumor Cells (CTC) Market report also includes individual market impact factors and domestic market regulatory changes impacting current and future market trends. Data points such as consumption volumes, production locations and volumes, import and export analysis, price trend analysis, raw material costs, downstream and upstream value chain analysis are some of the key indicators used to forecast the market scenario for individual countries. Additionally, the presence and availability of global brands and their challenges due to high or low competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered when providing forecast analysis of country data.

Health infrastructure growth Installed base and penetration of new technologies

Circulating Tumor Cells (CTC) Market also provides a detailed market analysis for each country, the growth in healthcare capital equipment spending, the installed base of different types of Circulating Tumor Cells (CTC) market products, the impact of the technology using lifeline curves and the changing regulatory landscapes in healthcare and their impact on the circulating tumor cell (CTC) market. Data is available for the historical period from 2010 to 2019.

(Video) Circulating Tumor Cells Market | Industry Data Analytics | IDA

competitive scenario andCirculating Tumor Cells (CTC) Marketshare analysis

Circulating Tumor Cells (CTC) market competitive landscape provides details by competitor. Details included are company overview, company finances, revenue generated, market potential, research and development investments, new market initiatives, global footprint, manufacturing locations and facilities, manufacturing capabilities, company strengths and weaknesses, product launch, product breadth and breadth, application domain. The data points provided above are only with focus of companies related to Circulating Tumor Cells (CTC) Market.

Major Players covered in Circulating Tumor Cells (CTC) Market report are Thermo Fisher Scientific Inc., GENERAL ELECTRIC, F. Hoffmann-La Roche Ltd., STEMCELL Technologies Inc., SRI INTERNATIONAL, QIAGEN, NanoString, Miltenyi Biotec, Menarini Silicon Biosystems ., Ikonisys, Inc., Greiner Bio One International GmbH, Precision Medicine Group, LLC, Creatv MicroTech, Inc., Aviva Systems Biology Corporation, Advanced Cell Diagnostics, Inc., iCellate AB, CytoLumina, Bio-Techne, Biocept, Inc ... . and Rarecells, Inc., among other national and global players. Market share data is available separately for Global, North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA) and South America. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Item number-

(Video) Circulating Tumor Cell Analysis: Delivering on the Promise of Liquid Biopsy


1. Circulating Tumor Cell Analysis: Delivering on the Promise of Liquid Biopsy
2. Insights into the biology of human circulating tumor cells and clinical implications
(ANGLE plc)
3. Circulating Tumor Cell (CTC) Detector Market | Industry Data Analytics | IDA
(Industry Data Analytics)
4. Role of Circulating Tumor Cells/DNA & Liquid Biopsy in Melanoma - David Polsky
5. Simultaneously isolating cfDNA and Circulating tumor cells (CTCs) from a Single Sample | AACR 2015
(Thermo Fisher Scientific)
6. WEBINAR cellenion: Optimising circulating tumour cells isolation for scRNA-Seq analyses
Top Articles
Latest Posts
Article information

Author: Rueben Jacobs

Last Updated: 06/23/2023

Views: 6087

Rating: 4.7 / 5 (77 voted)

Reviews: 92% of readers found this page helpful

Author information

Name: Rueben Jacobs

Birthday: 1999-03-14

Address: 951 Caterina Walk, Schambergerside, CA 67667-0896

Phone: +6881806848632

Job: Internal Education Planner

Hobby: Candle making, Cabaret, Poi, Gambling, Rock climbing, Wood carving, Computer programming

Introduction: My name is Rueben Jacobs, I am a cooperative, beautiful, kind, comfortable, glamorous, open, magnificent person who loves writing and wants to share my knowledge and understanding with you.